AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |
Back to Blog
Dcis sentinel node biopsy12/12/2023 ![]() ![]() Ĭonsidering the controversy around pathogenesis and management of axillary metastases in DCIS, we reviewed our experience with sentinel lymph node biopsy (SLNB) among patients with DCIS. However, microinvasive foci are shown to be very difficult to detect especially in the case of very wide intraductal carcinoma. Some authors have described a prevalence of even 58.3% of occult invasion by histological re-examination of specimens of patients affected by DCIS with nodal metastasis, and thus significantly higher than that of specimens of pTisN0 patients. Microinvasion is defined as the extension of cancer cells beyond the basal membrane into the adjacent tissues, sized ≤1 mm, but a recent study hypothesized that tumor cell dissemination may also occur before stroma invasion. Nodal involvement in DCIS likely depends on the misdetection of occult microscopic invasive foci (occult microinvasion) due to technical limitations in specimen pathological assessment. Even in the absence of an evident invasive component, microinvasion should always be suspected in these cases, and their management should be the same as for IDC.Īlthough usually in situ cancer should not be able to shed neoplastic cells into the bloodstream or infiltrate the lymphatic net, there is a variable reported percentage of ductal carcinoma in situ (DCIS) which present an axillary nodal involvement, with higher rates noted in the premammographic era. Our study suggests that despite its rarity, sentinel node metastasis may also occur in case of DCIS, which in most cases are micrometastases. Predictors for the microinvasive component in DCIS were tumor multifocality/multicentricity, grading ≥2, ITCs and micrometastases. Significant predictors for distant metastases were DCISM, IDC, macroscopic nodal metastasis, and tumor grading ≥2. IDC, tumor grading ≥2 and lymph node (LN) macrometastasis were significant predictors for decreased overall survival. 5-year local recurrence rate of DCIS and DCISM were respectively 2.5% and 7.9%, and their 5-year distant recurrence rate respectively 0% and 4%. 5-year disease-free survival and overall survival in DCISM and IDC were similar, while significantly longer in DCIS. In cases of DCIS and DCISM, SLNB resulted micrometastatic respectively in 1.7% and 6.0% of cases and macrometastatic respectively in 0.9% and 3.6% of cases. We collected retrospective data on patients operated on their breasts for DCIS (pTis), DCIS with microinvasion (DCISM) (pT1mi) and invasive ductal carcinoma (IDC) sized ≤2 cm (pT1) between January 2002 and June 2016, focusing on the result of SLNB.ĥ43 DCIS, 84 DCISM, and 2111 IDC were included. Our experience with sentinel lymph node biopsy (SLNB) among patients with DCIS is reviewed. ![]() All rights reserved.With the introduction of an organized mammographic screening, the incidence of ductal carcinoma in situ (DCIS) has experienced an important increase. Given the potential increased morbidity and financial implications, this finding represents an opportunity for further education and improvement in patient selection for SLNB.Ĭopyright © 2020 Elsevier Inc. Despite this, nearly one in five patients undergoing BCS for DCIS had lymph node sampling performed. The role of SLNB in patients with DCIS undergoing BCS is limited and does not routinely provide meaningful information or benefit to clinical management. Positive sentinel nodes metastasis was identified in 0.9% patients undergoing BCS and SLNB for DCIS. A multivariate analysis demonstrated a significant association between greater frequency of SLNB in patients age range of 60-69, receipt of care at a community facility, and higher nuclear grade DCIS. We identified 15,422 patients with DCIS undergoing BCS in 2015, of which 2,698 (18%) underwent SLNB. A multivariate analysis was performed for patient and hospital characteristics. Patient demographics and hospital characteristics were grouped for analytic purposes. The purpose of this study is to assess national surgical practice patterns and clinical outcomes with respect to the use of SLNB for DCIS in patients undergoing breast conserving surgery (BCS).Ĭase-level data from the National Cancer Data Base (NCDB) was assessed to identify adult patients ≥ 18 with DCIS, who underwent BCS and SLNB. Although SLNB is typically a safe procedure, there are potential complications and associated costs. The role of sentinel lymph node biopsy (SLNB) for patients with ductal carcinoma in-situ (DCIS) is limited given the rarity of nodal metastasis in non-invasive disease. ![]()
0 Comments
Read More
Leave a Reply. |